Fiedorowicz Jess G, Solomon David A, Endicott Jean, Leon Andrew C, Li Chunshan, Rice John P, Coryell William H
Department of Psychiatry, Roy J. and Lucille A. Carver College of Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
Psychosom Med. 2009 Jul;71(6):598-606. doi: 10.1097/PSY.0b013e3181acee26. Epub 2009 Jun 26.
To compare the risk for cardiovascular mortality between bipolar I and bipolar II subtypes and determine correlates of cardiovascular mortality. Bipolar disorder conveys an increased risk of cardiovascular mortality.
Participants with major affective disorders were recruited for the National Institute of Mental Health Collaborative Depression Study and followed prospectively for up to 25 years. A total of 435 participants met the diagnostic criteria for bipolar I (n = 288) or bipolar II (n = 147) disorder based on Research Diagnostic Criteria at intake and measures of psychiatric symptoms during follow-up. Diagnostic subtypes were contrasted by cardiovascular mortality risk using Cox proportional hazards regression. Affective symptom burden (the proportion of time with clinically significant manic/hypomanic or depressive symptoms) and treatment exposure were additionally included in the models.
Thirty-three participants died from cardiovascular causes. Participants with bipolar I disorder had more than double the cardiovascular mortality risk of those with bipolar II disorder, after controlling for age and gender (hazard ratio = 2.35, 95% Confidence Interval = 1.04-5.33; p = .04). The observed difference in cardiovascular mortality between these subtypes was at least partially confounded by the burden of clinically significant manic/hypomanic symptoms which predicted cardiovascular mortality independent of diagnosis, treatment exposure, age, gender, and cardiovascular risk factors at intake. Selective serotonin uptake inhibitors seemed protective although they were introduced late in follow-up. Depressive symptom burden was not related to cardiovascular mortality.
Participants with bipolar I disorder may face a greater risk of cardiovascular mortality than those with bipolar II disorder. This difference in cardiovascular mortality risk may reflect manic/hypomanic symptom burden.
比较I型双相情感障碍和II型双相情感障碍亚型之间心血管疾病死亡风险,并确定心血管疾病死亡的相关因素。双相情感障碍会增加心血管疾病死亡风险。
招募患有重度情感障碍的参与者参加美国国立精神卫生研究所协作抑郁研究,并进行长达25年的前瞻性随访。共有435名参与者在入组时符合基于研究诊断标准的I型双相情感障碍(n = 288)或II型双相情感障碍(n = 147)的诊断标准,并在随访期间接受了精神症状测量。使用Cox比例风险回归对比诊断亚型的心血管疾病死亡风险。模型中还额外纳入了情感症状负担(临床上显著的躁狂/轻躁狂或抑郁症状出现的时间比例)和治疗暴露情况。
33名参与者死于心血管疾病。在控制年龄和性别后,I型双相情感障碍参与者的心血管疾病死亡风险是II型双相情感障碍参与者的两倍多(风险比 = 2.35,95%置信区间 = 1.04 - 5.33;p = 0.04)。这些亚型之间观察到的心血管疾病死亡差异至少部分被临床上显著的躁狂/轻躁狂症状负担所混淆,该症状负担独立于诊断、治疗暴露、年龄、性别和入组时的心血管风险因素预测心血管疾病死亡。选择性5-羟色胺再摄取抑制剂似乎具有保护作用,尽管它们在随访后期才开始使用。抑郁症状负担与心血管疾病死亡无关。
I型双相情感障碍参与者可能比II型双相情感障碍参与者面临更大的心血管疾病死亡风险。这种心血管疾病死亡风险的差异可能反映了躁狂/轻躁狂症状负担。